Yao Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yao Xiao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chao Zhang
Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
1 shared publication - Fan Xiao
Department of Respiratory and Critical Care Medicine Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang P. R. China
1 shared publication Haoxiang Chen
Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China
1 shared publicationHonghui Cai
Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China
1 shared publicationJinyue Fan
Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China
1 shared publicationLingyan Lu
Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9, 1293
DNA Nanotechnology-Enabled Precise Regulation of Nanozymes and Their Applications
Nanozymes overcome key limitations of natural enzymes, including poor environmental tolerance, high production costs, and batch-to-batch variability, with their enhanced physicochemical stability and controllable catalytic performance, thus enabling applications in biocatalysis and disease theranostics. However, their practical applications remain limited by insufficient catalytic efficiency, inadequate target specificity, and restricted programmable dynamic adaptability. DNA nanotechnology offers a versatile and biocompatible framework for the precise regulation of nanozymes due to its sequence-defined programmability and precise molecular recognition capability. This approach improves catalytic performance while maintaining excellent biocompatibility and low immunogenicity. This review systematically summarizes the latest advances in DNA nanotechnology-mediated precise regulation of nanozymes, with particular emphasis on the mechanistic basis of 6 regulatory modes. We further examine the representative applications of these DNA–nanozyme hybrid systems in disease therapy, biomedical sensing, and environmental monitoring, and outline the key challenges and future directions toward clinical and industrial translation.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9, 1293
Open AccessDNA Nanotechnology-Enabled Precise Regulation of Nanozymes and Their Applications
Nanozymes overcome key limitations of natural enzymes, including poor environmental tolerance, high production costs, and batch-to-batch variability, with their enhanced physicochemical stability and controllable catalytic performance, thus enabling applications in biocatalysis and disease theranostics. However, their practical applications remain limited by insufficient catalytic efficiency, inadequate target specificity, and restricted programmable dynamic adaptability. DNA nanotechnology offers a versatile and biocompatible framework for the precise regulation of nanozymes due to its sequence-defined programmability and precise molecular recognition capability. This approach improves catalytic performance while maintaining excellent biocompatibility and low immunogenicity. This review systematically summarizes the latest advances in DNA nanotechnology-mediated precise regulation of nanozymes, with particular emphasis on the mechanistic basis of 6 regulatory modes. We further examine the representative applications of these DNA–nanozyme hybrid systems in disease therapy, biomedical sensing, and environmental monitoring, and outline the key challenges and future directions toward clinical and industrial translation.